Retraction: Sunlight exposure is important for preventing hip fractures in patients with Alzheimer’s disease, Parkinson’s disease, or stroke : Fracture prevention by sunlight exposure (Acta Neurologica Scandinavica, (2012), 125, 4, (279-284), 10.1111/j.1600-0404.2011.01555.x);Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke

Acta Neurologica Scandinavica

Volumn 125, Issue 4, 2012, Pages 279-284

  Iwamoto, J ^a   Takeda, T ^a   Matsumoto, H ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Hip fracture; Parkinson's disease; Stroke; Sunlight; Vitamin D

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BONE DENSITY; HIP FRACTURE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; STROKE; SUN EXPOSURE; SUNLIGHT; VITAMIN D DEFICIENCY;

EID: 84858284242     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12940     Document Type: Erratum

References (29)

1. Epstein S. Tmenopausal osteoporosis: fracture consequences and treatment efficacy vary by skeletal site. Aging (Milano) 2000;12:330-41.
2. Nurmi I, Narinen A, Luthje P, Tanninen S. Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients. Arch Orthop Trauma Surg 2003;123:551-4.
3. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987;257:1492-5.
4. Weller I, Schatzker J. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 2004;14:319-24.
5. Baker NL, Cook MN, Arrighi HM, Bullock R. Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007. Age Ageing 2011;40:49-54.
6. Grisso JA, Kelsey JL, Strom BL et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326-31.
7. Kang JH, Chung SD, Xirasagar S, Jaw FS, Lin HC. Increased risk of stroke in the year after a hip fracture: a population-based follow-up study. Stroke 2011;42:336-41.
8. Melton LJ III, Leibson CL, Achenbach SJ et al. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord 2006;21:1361-7.
9. Sato Y, Iwamoto J, Kanoko T, Satoh K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2005;20:1327-33.
10. Sato Y, Iwamoto J, Honda Y. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson's disease. Parkinsonism Relat Disord 2011;17:22-6.
11. Sato Y, Metoki N, Iwamoto J, Satoh K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients. Neurology 2003;61:338-42.
12. Iwamoto J, Matsumoto H, Takeda T. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2008;24:1379-84.
13. 2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials. Clin Drug Investig 2009;29:471-9.
14. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Clin Epidemiol 2005;58:882-93.
15. Beadle PC. Sunlight, ozone and vitamin D. Br J Dermatol 1977;97:585-91.
16. Lestter E, Skinner RK, Foo AY, Lund B, Sorensen OH. Serum 25-hydroxyvitamin D levels and vitamin D intake in healthy young adults in Britain and Denmark. Scand J Clin Lab Invest 1980;49:145-50.
17. Sato Y, Inose M, Higuchi I, Higuchi F, Kondo I. Changes in the supporting muscles of the fractured hip in elderly women. Bone 2002;30:325-30.
18. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.
19. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
20. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005;20:187-92.
21. Epstein S. Is cortical bone hip? What determines cortical bone properties? Bone 2007;41(Suppl 1):S3-8.
22. Iwamoto J, Miyata A, Sato Y, Takeda T, Matsumoto H. Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures. Ther Clin Risk Manag 2009;5:773-9.
23. Iwamoto J, Sato Y, Takeda T, Matsumoto H. Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature. Clin Interv Aging 2008;3:1-7.
24. Bischoff HA, Borchers M, Guadt F et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001;33:19-24.
25. Sato Y, Iwamoto J, Honda Y. An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients. J Stroke Cerebrovasc Dis 2011;20:41-6.
26. Iwamoto J, Suzuki H, Tanaka K et al. Preventative effect of exercise against falls in the elderly: a randomized controlled trial. Osteoporos Int 2009;20:1233-40.
27. Harada A, Mizuno M, Takemura M, Tokuda H, Okuizumi H, Niino N. Hip fracture prevention trial using hip protectors in Japanese nursing homes. Osteoporos Int 2001;12:215-21.
28. Van Schoor NM, Smit JH, Twisk JW, Bouter LM, Lips P. Prevention of hip fractures by external hip protectors: a randomized controlled trial. JAMA 2003;289:1957-62.
29. Runge M, Hunter G. Determinants of musculoskeletal frailty and the risk of falls in old age. J Musculoskelet Neuronal Interact 2006;6:167-73.